We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Molecular Partners AG | NASDAQ:MOLN | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.67 | 11.26% | 6.62 | 6.62 | 6.69 | 6.81 | 6.55 | 6.80 | 84,389 | 15:58:06 |
A live webcast of the event will be available on the "News and Events" page in the "Events" section of the Company's website. A replay of the webcast will be archived on the Company's website for 1 year following their respective presentation dates.
About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company developing DARPin (designed ankyrin repeat protein) therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of oncology and virology and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com Find us on Twitter - @MolecularPrtnrs
For further details, please contact:Seth Lewis, Investor Relationsseth.lewis@molecularpartners.comTel: +1 781 420 2361
Antonio Ligi, CommunicationsZurich-Schlieren, Switzerlandantonio.ligi@molecularpartners.comTel: +41 79 723 36 81
1 Year Molecular Partners Chart |
1 Month Molecular Partners Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions